[1]
R. EL-Mernissi, “3D-QSAR, ADMET and Docking Studies for Design New 5,5-Diphenylimidazolidine-2,4-dione Derivatives Agents Against Cervical Cancer ”, Orbital: Electron. J. Chem., vol. 14, no. 1, pp. 24-32, Apr. 2022.